Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II

Diabetes treatment cost represents an ever-growing problem. The adoption of new drugs in therapy, although they can guarantee an improvement in patient’s quality of life, can meet obstacles when it involves an increase in costs. We decided to compare the costs and benefits of the new saxagliptin and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Health Serv Insights
Asıl Yazarlar: Torre, Enrico, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Valentino, Maria Chiara, Bottaro, Luigi Carlo, Colombo, Giorgio Lorenzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298424/
https://ncbi.nlm.nih.gov/pubmed/32595277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1178632920929982
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller